A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors. (18th June 2013) - Stuurman, F.E.; Lolkema, M.P.; Huitema, A.D.R.; Soetekouw, P.M.M.B.; Rosing, H.; Rolfe, L.; Kaur, P.; Beijnen, J.H.; van Tinteren, H.; Voest, E.E.; Schellens, J.H.M.